BACKGROUND AND PURPOSE: Multiple patient-specific clinical and radiologic parameters impact traditional perfusion thresholds used to classify/determine tissue outcome. We sought to determine whether modified baseline perfusion thresholds calculated by integrating baseline perfusion and clinical factors better predict tissue fate and clinical outcome. MATERIALS AND METHODS: CTP within 4.5 hours of acute anterior circulation stroke onset and 5- to 7-day MR imaging were performed for 203 patients with stroke, divided into derivation (n = 114) and validation (n = 89) data bases. Affected regions were operationally classified as infarct and noninfarct according to baseline CTP and follow-up FLAIR imaging. Perfusion thresholds were derived for each of the infarct and noninfarct regions, without and with transformation by baseline clinical and radiologic variables by using a general linear mixed model. Performance of transformed and nontransformed perfusion thresholds for tissue fate and 90-day clinical outcome prediction was then tested in the derivation data base. Reproducibility of models was verified by using bootstrapping and validated in an independent cohort. RESULTS: Perfusion threshold transformation by clinical and radiologic baseline parameters significantly improved tissue fate prediction for both gray matter and white matter (P < .001). Transformed thresholds improved the 90-day outcome prediction for CBF and time-to-maximum (P < .001). Transformed relative CBF and absolute time-to-maximum values demonstrated maximal GM and WM accuracies in the derivation and validation cohorts (relative CBF GM: 91%, 86%; WM: 86%, 83%; absolute time-to-maximum 88%, 79%, and 80%, 76% respectively). CONCLUSIONS: Transformation of baseline perfusion parameters by patient-specific clinical and radiologic parameters significantly improves the accuracy of tissue fate and clinical outcome prediction.
BACKGROUND AND PURPOSE: Multiple patient-specific clinical and radiologic parameters impact traditional perfusion thresholds used to classify/determine tissue outcome. We sought to determine whether modified baseline perfusion thresholds calculated by integrating baseline perfusion and clinical factors better predict tissue fate and clinical outcome. MATERIALS AND METHODS:CTP within 4.5 hours of acute anterior circulation stroke onset and 5- to 7-day MR imaging were performed for 203 patients with stroke, divided into derivation (n = 114) and validation (n = 89) data bases. Affected regions were operationally classified as infarct and noninfarct according to baseline CTP and follow-up FLAIR imaging. Perfusion thresholds were derived for each of the infarct and noninfarct regions, without and with transformation by baseline clinical and radiologic variables by using a general linear mixed model. Performance of transformed and nontransformed perfusion thresholds for tissue fate and 90-day clinical outcome prediction was then tested in the derivation data base. Reproducibility of models was verified by using bootstrapping and validated in an independent cohort. RESULTS: Perfusion threshold transformation by clinical and radiologic baseline parameters significantly improved tissue fate prediction for both gray matter and white matter (P < .001). Transformed thresholds improved the 90-day outcome prediction for CBF and time-to-maximum (P < .001). Transformed relative CBF and absolute time-to-maximum values demonstrated maximal GM and WM accuracies in the derivation and validation cohorts (relative CBF GM: 91%, 86%; WM: 86%, 83%; absolute time-to-maximum 88%, 79%, and 80%, 76% respectively). CONCLUSIONS: Transformation of baseline perfusion parameters by patient-specific clinical and radiologic parameters significantly improves the accuracy of tissue fate and clinical outcome prediction.
Authors: Gustavo Saposnik; Jiming Fang; Moira K Kapral; Jack V Tu; Muhammad Mamdani; Peter Austin; S Claiborne Johnston Journal: Stroke Date: 2012-02-03 Impact factor: 7.914
Authors: Krishna A Dani; Ralph G R Thomas; Francesca M Chappell; Kirsten Shuler; Mary J MacLeod; Keith W Muir; Joanna M Wardlaw Journal: Ann Neurol Date: 2011-07-27 Impact factor: 10.422
Authors: Ona Wu; Toshihisa Sumii; Minoru Asahi; Masao Sasamata; Leif Ostergaard; Bruce R Rosen; Eng H Lo; Rick M Dijkhuizen Journal: J Cereb Blood Flow Metab Date: 2006-05-10 Impact factor: 6.200
Authors: T G Kwiatkowski; R B Libman; M Frankel; B C Tilley; L B Morgenstern; M Lu; J P Broderick; C A Lewandowski; J R Marler; S R Levine; T Brott Journal: N Engl J Med Date: 1999-06-10 Impact factor: 91.245
Authors: Shervin Kamalian; Shahmir Kamalian; A A Konstas; M B Maas; S Payabvash; S R Pomerantz; P W Schaefer; K L Furie; R G González; M H Lev Journal: AJNR Am J Neuroradiol Date: 2011-12-22 Impact factor: 3.825
Authors: E M Fanou; J Knight; R I Aviv; S-P Hojjat; S P Symons; L Zhang; M Wintermark Journal: AJNR Am J Neuroradiol Date: 2015-10-15 Impact factor: 3.825
Authors: Steven J Warach; Marie Luby; Gregory W Albers; Roland Bammer; Andrew Bivard; Bruce C V Campbell; Colin Derdeyn; Jeremy J Heit; Pooja Khatri; Maarten G Lansberg; David S Liebeskind; Charles B L M Majoie; Michael P Marks; Bijoy K Menon; Keith W Muir; Mark W Parsons; Achala Vagal; Albert J Yoo; Andrei V Alexandrov; Jean-Claude Baron; David J Fiorella; Anthony J Furlan; Josep Puig; Peter D Schellinger; Max Wintermark Journal: Stroke Date: 2016-04-12 Impact factor: 7.914
Authors: Mark Krongold; Mohammed A Almekhlafi; Andrew M Demchuk; Shelagh B Coutts; Richard Frayne; Armin Eilaghi Journal: Neuroimage Clin Date: 2014-11-08 Impact factor: 4.881
Authors: Eric A Wright; Christopher D d'Esterre; Laura B Morrison; Neil Cockburn; Michael Kovacs; Ting-Yim Lee Journal: PLoS One Date: 2016-06-27 Impact factor: 3.240